NSBNEUROSCIENTIFIC BIOPHARMACEUTICALS LTDMarket sensitive

Leading CRO Appointed for Phase 2 Crohn's Trial

Date and time
Announcement type
Company Update

More from Health Care

More News

OMACompany Update19 November 2026

Omega Oil & Gas (ASX: OMA) Extends Taroom Trough Play 25km